Skip to Content Facebook Feature Image

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Business

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Business

Business

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

2026-08-03 23:51 Last Updated At:08-04 00:00

NEW YORK--(BUSINESS WIRE)--Aug 3, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803149922/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company may have misled investors about the importance of Fabric Genomics; (2) as a result, the Company’s margins would suffer; (3) the company’s average reimbursement rates were not as “durable” as previously disclosed; (4) as a result of the foregoing, the Company’s gross margins would decline; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

On May 4, 2026, the price of the Company's shares closed at $67.93. After hours, the Company disclosed that its Q1 financial results had missed for both its exome and genome lines, and cut its 2026 guidance from $540-555 million to $475-490 million.

During the related earnings call, the Company disclosed that the average reimbursement rate came in at $3,300, or $200 below expectations. It also disclosed that it had taken a goodwill impairment charge of $31.3 million as a part of the Fabric Genomics acquisition – after paying $36.5 million for the Company only a year before.

On this news, GeneDx’s share price fell over 49%, or $33.42 per share, from the close on the previous day.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding GeneDx’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the GeneDx class action, go to www.faruqilaw.com/WGS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the GeneDx Holdings Corp. Securities Class Action Lawsuit:

What is the GeneDx Holdings securities fraud lawsuit about?

The GeneDx Holdings securities fraud lawsuit is a federal securities class action alleging that GeneDx Holdings Corp. (NASDAQ: WGS) and its executives made false and misleading statements to investors by misrepresenting the importance and value of its Fabric Genomics acquisition, overstating the durability of its average reimbursement rates, and concealing that the Company's gross margins would decline as a result. As the truth emerged on May 4, 2026 — when GeneDx disclosed that Q1 results had missed expectations across both its exome and genome lines, cut its 2026 revenue guidance from $540–$555 million down to $475–$490 million, revealed that average reimbursement rates came in at $3,300 (approximately $200 below expectations), and disclosed a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition it had purchased for $36.5 million just one year prior — WGS shares fell over 49%, or $33.42 per share, in a single day, causing significant losses for investors.

Who may be eligible to participate in the GeneDx Holdings class action lawsuit?

Investors who purchased or acquired GeneDx Holdings (WGS) stock between April 16, 2025 and May 4, 2026 — the Class Period — and suffered financial losses may be eligible to participate in the GeneDx securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former GeneDx employees, and others with relevant information about the Company's conduct are also encouraged to come forward.

What is a lead plaintiff, and how can I seek appointment in the GeneDx Holdings lawsuit?

A lead plaintiff in the GeneDx Holdings class action is a court-appointed investor — typically the one with the largest financial interest in the case — who directs and oversees the litigation on behalf of all class members. Any GeneDx investor who purchased WGS stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is August 3, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.

What should investors do if they purchased GeneDx Holdings stock during the Class Period?

Investors who purchased GeneDx Holdings (WGS) stock between April 16, 2025 and May 4, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the GeneDx Holdings securities class action is August 3, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/WGS for more information.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Acting Attorney General Todd Blanche has put it in writing, issuing a formal order terminating President Donald Trump’s $1.8 billion “anti-weaponization fund” to compensate his political allies. The move follows weeks of negotiations with two Republican senators who were blocking his nomination for the permanent job.

The order leaves in place a declaration — rejected by a judge as improper self-dealing — giving Trump and his family retroactive immunity for any tax audits.

Trump says new talks to wind down the war in Iran will start Monday afternoon, after announcing he's holding off on another massive wave of strikes. His comments once again brought oil prices down on hopes of reviving shipments through the Strait of Hormuz.

Immigration remains a stronger issue for Trump than the economy or Iran, according to a new AP-NORC poll, even after three people were killed in encounters with Immigration and Customs Enforcement last month.

Here is the latest:

Trump is venting about the status of peace talks with Iran.

He criticized Iran's leadership for claiming that its meetings with Oman on Monday were focused solely on establishing a temporary route for safe navigation through the Strait of Hormuz.

The president previously said he held off on a massive weekend strike against Iran because there was another framework for a ceasefire and the full reopening of the strait to oil and natural gas tankers.

“Iranian Leadership is unbelievably duplicitous!” Trump posted on social media Monday. “They ask for a meeting, some would say “beg,” talks begin, with more scheduled in the immediate future, and they say, openly and proudly, that they’re not having any discussions, that nothing is being talked about, and they’re only dealing with ‘Oman.’”

Trump said whether “Iran wants to admit it or not, we are, in fact, talking” about preventing Iran from developing nuclear weapons.

The Trump administration is packing immigration courtrooms with speedier hearings to clear a decades-long backlog in asylum claims. New data shows a historic rise in missed court dates and immediate deportation orders as judges struggle to keep up the pace.

Hundreds of immigrants’ cases a day are being assigned to individual judges as the number of “mega” master hearings significantly increase. More than 1,300 were held in June alone, a nearly threefold jump from the previous June, according to Mobile Pathways, a nonprofit that tracks immigration court data.

The data also shows that courts have severely cut preparation time in complex immigration proceedings, so people are missing hearings and being told they’ve abandoned their asylum claims at unprecedented rates.

Those who favor limiting immigration see this as a course-correction for a longstanding problem. But the nonprofit’s chief operating officer says cases are being closed without being heard.

▶ Read more

Two Republican senators who threatened to block acting Attorney General Todd Blanche’s bid to lead the Justice Department said Monday that they will vote to advance his nomination, ending an impasse over plans to create a fund to compensate the president’s allies.

The statement from Republican Sen. John Cornyn and Thom Tillis came after Blanche issued an order late Sunday formally rescinding the $1.8 billion “Anti-Weaponization Fund” to compensate people who believe they were unfairly prosecuted by the Justice Department.

Cornyn and Tillis had said they would not support Blanche’s nomination without written confirmation that the fund is dead.

▶ Read more

The president knows the world hangs on his every word. Now he wants you to pay for it.

Trump’s Truth Social business began selling sneak peeks of his social media posts on Saturday, offering early access to market-moving news to Wall Street traders willing to pay up. The move raises the prospect of big profits for Trump’s company, and big questions about insider trading and using public office for private gain.

Similar fast-speed feeds are sold by other social media firms and media providers, but Truth Social doesn’t just distribute the news, it makes it as Trump announces changes on everything from war to central bank leadership to tariffs.

“If this was the CEO of a public company, this would be jail time,” said Irene Aldridge, head of Able Alpha Trading.

Initial sales details may be disclosed when Truth Social’s parent company announces quarterly earnings.

▶ Read more

Tuesday’s Senate primary in Michigan between congresswoman Haley Stevens and public health official Abdul El-Sayed is one of the clearest tests yet of where Democratic voters want their party to go.

El-Sayed is a progressive backed by Sen. Bernie Sanders who’s run against much of the Democratic establishment. Stevens is backed by Senate Democratic leader Chuck Schumer and has made electability and experience central to her case.

The winner faces Republican Mike Rogers in November for an open seat Democrats likely need to hold to take control of the Senate next year.

▶ Read more

The U.S. president said on social media that independent surveys showing low approval ratings are false — denying a clear trend of lower support for Trump because of inflation and the Iran war, among other issues.

“My REAL Polling Numbers, not those made up by the Fake News Media, are the best they have ever been,” Trump asserted, providing no data to back up his claim.

The AP-NORC Center for Public Affairs Research found that just 33% of U.S. adults approve of Trump. That survey from late July also showed a drop since the start of Trump’s second term in adults who “strongly approve” of him.

Contrary to the evidence of multiple surveys, Trump said his popularity is based on his income tax cuts, his job numbers, his efforts to secure the U.S. border with Mexico and his use of American military force in Venezuela and Iran.

The White House said the president will go to California and Nevada to talk up the economy and border security and slam Democrats ahead of the November elections.

Trump on Tuesday will attend a Republican National Committee dinner at the Trump National Golf Club in Los Angeles.

On Wednesday, the president is slated to talk about the economy at Red Rock Casino in Las Vegas.

Oil prices are easing and helping to calm Wall Street’s worries that inflation could potentially get even worse. That has U.S. stock indexes rising early Monday, but several major chip stocks are falling again including Micron and AMD.

The S&P 500 rose 0.4%. The Dow Jones Industrial Average added 625 points, and the Nasdaq composite rose 0.2%. The price of a barrel of Brent crude fell 5.1% to $83.42 after Trump said over the weekend he would hold off on ordering new strikes against Iran at the urging of allies in the region. Treasury yields fell.

▶ Read more

The Trump administration is planning a dramatic overhaul of Head Start that would gut its quality standards, two people familiar with the deliberations said.

Head Start, established in the 1960s to help fight poverty, has long been considered by experts to be a gold standard for early education. It has more than 100 pages of regulations that cover everything from child-to-teacher ratios and child health screenings to family engagement.

The Republicans would replace these with around a dozen pages of rules that leave most specifics to state and local law, said the people, who spoke on condition of anonymity because the information is not yet public and they feared reprisal.

The draft rules would require more documentation from homeless or unemployed parents, and an early version would have barred even the U.S. citizen children of parents who are in the United States illegally.

▶ Read more

The U.S. dollar weakened sharply against the Japanese yen on Monday after Trump and Japan’s finance minister confirmed that both sides had intervened in markets.

The yen’s prolonged weakness against the dollar has been a source of frustration for Tokyo. Since Japan imports so much of what it consumes, a weak currency pushes prices higher. High oil prices have amplified pressure on Prime Minister Sanae Takaichi to do more to address the rising cost of living.

Normally, foreign exchange markets determine the relative values of currencies, and officials usually stay mum on any interventions, but Trump confirmed it on Sunday.

A weaker dollar makes U.S.-made goods more competitive. Analysts are describing the intervention as a “low-cost” way for Washington to pay a favor to a key U.S. ally.

▶ Read more

The document released by Blanche on Sunday night keeps a provision of the IRS settlement that provided broad tax-audit immunity for Trump and family, while limiting its scope.

It clarifies that the immunity “applies by its terms only retroactively” to claims open at the time of the settlement, and does not protect the president from examination of future tax filings.

On Friday, Trump’s attorneys notified a court they would appeal a judge’s scathing ruling that characterized the settlement of the president’s lawsuit against the IRS as an improper exercise in self-dealing.

The judge said that because Trump manipulated the court system by suing an agency he controls, the government cannot claim in official proceedings that the agreement resulted from a legitimate legal process.

Trump said new talks to wind down the war in Iran and revive traffic through the Strait of Hormuz will start Monday afternoon, after announcing he is holding off on new massive strikes he had threatened to unleash on the country. Iranian state media, however, quoted the country’s foreign ministry as saying Tehran was not currently holding negotiations with the United States.

Israel struck the Gaza Strip again over the weekend, after the U.S. and Hamas said a deal was reached for the militant group to disarm, a potential step toward ending the war in Gaza that depends on Israel stopping its attacks. The Israeli military said the strikes targeted militant operatives.

Hospitals in Gaza said at least 17 people were killed, including children. A strike on one residential apartment killed three family members including a 4-year-old child, according to Nasser hospital, where the bodies arrived.

▶ Read more

Immigration remains a stronger issue for Trump than the economy or Iran, according to a new AP-NORC poll, even after three people were killed in encounters with Immigration and Customs Enforcement in July.

Trump is not getting a glowing endorsement on his immigration approach from Americans overall, the new survey from The Associated Press-NORC Center for Public Affairs Research found: Only 39% of U.S. adults approve of his performance on immigration, a decline from 49% at the beginning of his second term.

Despite that, about 8 in 10 Republicans continue to approve of how Trump is handling immigration. That’s a slight decline from the beginning of Trump’s second term, when about 9 in 10 Republicans approved, but his support within his base has been mostly stable despite a chaotic year of immigration enforcement actions.

▶ Read more

Trump has played this hand before during the 5-month-old Iran war.

It starts with a grim warning to Tehran that he’s on the cusp of ordering U.S. forces to “obliterate” its power plants or seize key parts of its oil industry if its leaders don’t quickly agree to U.S. terms to end the war. It ends with him edging away with a last-minute declaration, sometimes at the behest of Gulf allies, that he’s going to give diplomacy more time.

The hardball strategy aims to create movement in negotiation through pressure and chaos. But the tactic is facing a challenge with an Iranian theocracy that believes it holds a higher threshold for strategic pain than Washington.

The latest episode began on Friday when Trump grimly declared that he was “losing faith” in negotiations with Iran and warned that the U.S. military “ will be hitting them very hard.”

But by late Saturday night, Trump declared on social media that there were signs of progress on reaching an agreement and so he was calling off a plan to carry out new, massive strikes for the time being.

▶ Read more

Acting Attorney General Todd Blanche finally put it in writing, issuing a formal order late Sunday terminating Trump’s $1.8 billion “anti-weaponization fund” to compensate his political allies. The move follows weeks of negotiations with two Republican senators who were blocking his nomination for the permanent job.

A spokeswoman for Texas Sen. John Cornyn confirmed the deal, which comes ahead of a Tuesday confirmation vote for Blanche’s nomination in the Senate Judiciary Committee. The other GOP senator, North Carolina Sen. Thom Tillis, did not have immediate comment.

Blanche said at a June hearing that the Justice Department would not move forward with the fund to compensate those who believe they were unfairly prosecuted, as he faced bipartisan outrage over the possibility that violent rioters who attacked police at the U.S. Capitol on Jan. 6, 2021, could be considered for payments. But Cornyn and Tillis, both members of the Judiciary panel, have said they wanted to see the promise in writing before they endorsed Blanche’s nomination — especially as Trump continued to express support for the idea.

▶ Read more

Health and Human Services Secretary Robert F. Kennedy Jr., from left, acting Attorney General Todd Blanche and Vice President JD Vance attend a cabinet meeting, Friday, July 31, 2026, at Camp David, the presidential retreat, near Thurmont, Md., Friday, July 31, 2026. (AP Photo/Jacquelyn Martin)

Health and Human Services Secretary Robert F. Kennedy Jr., from left, acting Attorney General Todd Blanche and Vice President JD Vance attend a cabinet meeting, Friday, July 31, 2026, at Camp David, the presidential retreat, near Thurmont, Md., Friday, July 31, 2026. (AP Photo/Jacquelyn Martin)

President Donald Trump carries an umbrella as he exits Air Force One at Joint Base Andrews, Md., Sunday, Aug. 2, 2026, on return to Washington. (AP Photo/Jacquelyn Martin)

President Donald Trump carries an umbrella as he exits Air Force One at Joint Base Andrews, Md., Sunday, Aug. 2, 2026, on return to Washington. (AP Photo/Jacquelyn Martin)

Recommended Articles